Inactive Instrument

Asian Phytoceuticals PCL Stock price Thailand S.E.

Equities

Personal Products

End-of-day quote Thailand S.E.
- THB 0.00% Intraday chart for Asian Phytoceuticals PCL
Sales 2022 250M 6.88M Sales 2023 293M 8.04M Capitalization 3.12B 85.72M
Net income 2022 80M 2.2M Net income 2023 107M 2.94M EV / Sales 2022 11.3 x
Net cash position 2022 165M 4.54M Net cash position 2023 216M 5.92M EV / Sales 2023 9.92 x
P/E ratio 2022
37.1 x
P/E ratio 2023
29 x
Employees -
Yield 2022
3.1%
Yield 2023
3.46%
Free-Float 22.23%
More Fundamentals * Assessed data
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Asian Phytoceuticals Public Company Limited Appoints Montien Sirisoonthornlak as Director CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Asian Phytoceuticals Public Company Limited Announces the Establishment of Companies CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Asian Phytoceuticals Public Company Limited Announces Retirement of Executive Committee and Executives CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Asian Phytoceuticals Public Company Limited Announces the Progress of Apco's Research and Development CI
More news
Managers TitleAgeSince
Founder 78 76-12-31
Director of Finance/CFO 55 11-11-10
Chief Tech/Sci/R&D Officer 57 08-12-31
Members of the board TitleAgeSince
Director/Board Member 75 11-04-29
Director/Board Member 82 04-12-31
Chairman 78 11-04-29
More insiders
Asian Phytoceuticals Public Company Limited is a Thailand-based company, which is engaged in business of research and development, manufacturing, and distribution of its products for health and natural beauty. It operates through the manufacturing and distribution of dietary supplements from herbs. The Company’s products and brands include operation balancing immunity (BIM), longevity, and slimming and beauty products. Its operation BIM includes Mylife, LIV Capsule, Garcinia, Arthrinox, Diabenok, Tumorid capsule, Noriasis, Canvirol and others. The Company’s slimming products include Asian Life Revitalizing Serum, Asian Life Revitalizing Cream, Garcinia Acne Cream, Garcinia Facial Cleansing Gel, Garcinia Cleansing Cream, Noriasis Nourishing Skin Cream, and others. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Asian Phytoceuticals
  4. Stock Asian Phytoceuticals PCL - Thailand S.E.